Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04133584
What this trial is testing

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Who this might be right for
Seasonal InfluenzaHand, Foot and Mouth Disease
Zhejiang Provincial Center for Disease Control and Prevention 1,134
Testing effectiveness (Phase 2)Study completedNCT00945438
What this trial is testing

Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 131
Early research (Phase 1)Study completedNCT03028116
What this trial is testing

Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine

Who this might be right for
Influenza, Human
Research Institute for Biological Safety Problems 44
Large-scale testing (Phase 3)Study completedNCT05568797
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,045
Early research (Phase 1)Study completedNCT03893669
What this trial is testing

Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

Who this might be right for
Prevention of Influenza
SK Chemicals Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT01551810
What this trial is testing

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)

Who this might be right for
Influenza
Institute of Medical Biology, Chinese Academy of Medical Sciences 1,200
Post-approval studies (Phase 4)Study completedNCT01356316
What this trial is testing

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Adimmune Corporation 120
Post-approval studies (Phase 4)Study completedNCT01867021
What this trial is testing

Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Who this might be right for
Influenza
Novartis 2,902
Not applicableStudy completedNCT01411358
What this trial is testing

Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Adimmune Corporation 128
Post-approval studies (Phase 4)Study completedNCT01538940
What this trial is testing

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Who this might be right for
Influenza
Centers for Disease Control and Prevention 415
Testing effectiveness (Phase 2)Looking for participantsNCT06842173
What this trial is testing

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Who this might be right for
Avian Influenza A Virus
Butantan Institute 700
Early research (Phase 1)Ended earlyNCT03888989
What this trial is testing

Response to Influenza Vaccine During Pregnancy

Who this might be right for
Influenza
Stanford University 2
Early research (Phase 1)Study completedNCT03275389
What this trial is testing

Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

Who this might be right for
Influenza, Human
GlaxoSmithKline 470
Early research (Phase 1)Study completedNCT02151344
What this trial is testing

Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00662272
What this trial is testing

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

Who this might be right for
Influenza
Colby Pharmaceutical Company 128
Large-scale testing (Phase 3)Study completedNCT00464672
What this trial is testing

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Who this might be right for
Influenza
Novartis 1,893
Post-approval studies (Phase 4)Study completedNCT02062281
What this trial is testing

Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults

Who this might be right for
Pneumococcal InfectionInfluenza
Jiangsu Province Centers for Disease Control and Prevention 2,225
Testing effectiveness (Phase 2)Study completedNCT00992017
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 130
Testing effectiveness (Phase 2)Study completedNCT00918268
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Who this might be right for
Influenza Disease
Novartis Vaccines 130
Post-approval studies (Phase 4)Study completedNCT00893906
What this trial is testing

Inactivated Influenza Vaccine Effectiveness in Tropical Africa

Who this might be right for
Influenza
PATH 10,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation